Informal Caregivers’ Administration of Hospice Prescribed Lorazepam to Homecare Patients With Anxiety

Abstract

Background:

A growing number of informal caregivers (IFCs) manage hospice patients’ anxiety by administering lorazepam (Ativan), yet little is known about prescribing practices in home care or the extent to which IFCs carry out regimens.

Design and Methods:

Data on hospice prescribed lorazepam was determined through a retrospective review of medication records from 216 deceased patients. The dose of lorazepam and type of regimen (i.e., scheduled, PRN, combination) as well as frequency with which it was administered by IFCs was calculated upon admission to a residential care home and on patients’ day of death.

Results:

The majority (63.1%) of patients were prescribed lorazepam on admission to the home, and more (79.5%) were prescribed lorazepam on the day of death. While higher doses of lorazepam were prescribed and administered on the day of death, the percentage of medication consumed was low on admission (17%) and day of death (27%). Nearly all (92.8%) prescribed lorazepam on the day of death were allowed PRN medication. For PRN only regimens, less than a quarter (24.4%) of patients were given lorazepam on admission with less than half (40.4%) given it while dying. Highest lorazepam administration rates (91.2%) occurred on the day of death when lorazepam was prescribed under a combined regimen.

Conclusion:

The high frequency of PRN regimens reveal that IFCs are frequently tasked with making decisions about if and when to administer lorazepam. Low overall lorazepam administration suggests a closer monitoring of lorazepam use and enhanced support of IFCs may be needed.

Keywords

informal caregivers anxiety lorazepam regimen PRN hospice medication management residential care home

Get full access to this article

View all access options for this article.

References

Kozlov

Phongtankuel

Prigerson

, et al. Prevalence, severity, and correlates of symptoms of anxiety and depression at the very end of life. J Pain Symptom Manag. 2019;58(1):80–85. https://search.datacite.org/works/10.1016./j.jpainsymman.2019.04.012. doi:10.1016/j.jpainsymman.2019.04.012

Tang

Chen

Chou

, et al. Longitudinal analysis of severe anxiety symptoms in the last year of life among patients with advanced cancer: relationships with proximity to death, burden, and social support. J Natl Compr Canc Netw. 2016;14(6):727–734. https://www.ncbi.nlm.nih.gov/pubmed/27283165. doi:10.6004/jnccn.2016.0074

Ford

. The complexity of assessment and treatment for anxiety in patients with a terminal illness. J Hosp Palliat Nurs. 2016;18(2):131–138. doi:10.1097/NJH.0000000000000223

Zweers

de Graaf

Teunissen

. Suitable support for anxious hospice patients: what do nurses ‘know’, ‘do’ and ‘need’? An explanatory mixed method study. BMJ Support Palliat Care. 2020;10(2):e15. https://dx-doi-org.web.bisu.edu.cn/10.1136/bmjspcare-2016-001187. doi:10.1136/bmjspcare-2016-001187

Atkin

Vickerstaff

Candy

. ‘Worried to death’: the assessment and management of anxiety in patients with advanced life-limiting disease, a national survey of palliative medicine physicians. BMC Palliat Care. 2017;16(1):69. https://www.ncbi.nlm.nih.gov/pubmed/29224571. doi:10.1186/s12904-017-0245-5

Aldridge

Canavan

Cherlin

Bradley

. Has hospice use changed? 2000–2010 utilization patterns. Med Care. 2015;53(1):95–101. https://www.ncbi.nlm.nih.gov/pubmed/25373406. doi:10.1097/MLR.0000000000000256

Cross

Warraich

. Changes in the place of death in the United States. N Engl J Med. 2019;381(24):2369–2370. https://dx-doi-org.web.bisu.edu.cn/10.1056/NEJMc1911892. doi:10.1056/NEJMc1911892

Kamell

Smith

. Attitudes toward use of benzodiazepines among U.S. hospice clinicians: survey and review of the literature. J Palliat Med. 2016;19(5):516–522. https://www.liebertpub.com/doi/abs/10.1089/jpm.2015.0376. doi:10.1089/jpm.2015.0376

Elsayem

Curry

III E

Boohene

, et al. Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer. 2009;17(1):53–59. https://www.ncbi.nlm.nih.gov/pubmed/18461370. doi:10.1007/s00520-008-0459-4

10.

Advokat

Comaty

Julien

. Julien’s Primer of Drug Action. 13. Worth Publishers; 2014.

11.

Pariente

Dartigues

Benichou

Letenneur

Moore

Fourrier-Reglat

. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging. 2008;25(1):61–70. http://www.ingentaconnect.com/content/adis/dag/2008/00000025/00000001/art00007. doi:10.2165/00002512-200825010-00007

12.

Uzun

Kozumplik

Jakovljević

Sedić

. Side effects of treatment with benzodiazepines. Psychiatr Danub. 2010;22(1):90–93. https://www.ncbi.nlm.nih.gov/pubmed/20305598.

13.

Ghiasi

Bhansali

Marwaha

. Lorazepam. In: StatPearls. StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK532890/?report=classic. Accessed January 18, 2020.

14.

Campbell

Kelly

Rovnyak

. Pain management in home hospice patients: a retrospective descriptive study. Nurs Health Sci. 2017;19(3):381–387. doi:10.1111/nhs.12359

15.

Payne

Turner

Seamark

, et al. Managing end of life medications at home—accounts of bereaved family carers: a qualitative interview study. BMJ Support Palliat Care. 2015;5(2):181–188.

16.

Tjia

Ellington

Clayton

Lemay

Reblin

. Managing medications during home hospice cancer care: the needs of family caregivers. J Pain Symptom Manage. 2015;50(5):630–641. https://www.clinicalkey.es/playcontent/1-s2.0-S088539241500322X. doi:10.1016/j.jpainsymman.2015.06.005

17.

McNeil

Kamal

Kunter

Ritchie

Abernethy

. The burden of polypharmacy in patients near the end of life. J. Pain Symptom Manage. 2016;51:178–183.

18.

Vaismoradi

Amaniyan

Jordan

. Patient safety and pro re nata prescription and administration: a systematic review. Pharmacy (Basel). 2018;6(3):95. doi:10.3390/pharmacy6030095

19.

Arevalo

Geijteman

Huisman

, et al. Medication use in the last days of life in hospital, hospice, and home settings in the Netherlands. J Palliat Med. 2018;21(2):149–155. doi:10.1089/jpm.2017.0179

20.

Mayahara

Paice

Wilbur

Fogg

Foreman

. Common errors in using analgesics by home-based nonprofessional hospice caregivers. J Hospice Palliat Nurs. 2014;16(3):134–140. doi:10.1097/NJH.0000000000000040

21.

Joyce

Lau

. Hospice experiences and approaches to support and assess family caregivers in managing medications for home hospice patients: a providers survey. Palliat Med. 2013;27(4):329–338. https://journals-sagepub-com-s.web.bisu.edu.cn/doi/full/10.1177/0269216312465650. doi:10.1177/0269216312465650

22.

Lau

Berman

Halpern

Pickard

Schrauf

Witt

. Exploring factors that influence informal caregiving medication management for home hospice patients. J Palliat Med. 2010;13(9):1085–1090. doi:10.1089/jpm.2010.0082

23.

Sheehy-Skeffington

McLean

Bramwell

O’Leary

O’Gorman

. Caregivers experiences of managing medications for palliative care patients at the end of life. Am J Hosp Palliat Med. 2014;31(2):148–154. https://journals-sagepub-com-s.web.bisu.edu.cn/doi/full/10.1177/1049909113482514. doi:10.1177/1049909113482514

24.

Speer

Dioso

Casner

. Costs and implications of discarded medication in hospice. J Palliat Med. 2013;16(8):975–978. doi:10.1089/jpm.2013.0095

25.

Grant

Scott

. An introduction and overview of social model hospice care. J Hosp Palliat Nurs. 2015;17(5):456–461.

26.

Smith

Ona

. Mt Carmel House: a home for terminally ill patients who cannot go home. Cancer Invest. 1995;13(2):239–243.

27.

National Hospice and Palliative Care Organization. NHPCO Facts and Figures. 2018. https://39k5cm1a9u1968hg74aj3x51-wpengine.netdna-ssl.com/wp-content/uploads/2019/07/2018_NHPCO_Facts_Figures.pdf. Accessed April 14, 2020.

28.

Stawicki

. Common sedative agents: an overview. Int J Acad Med. 2017;3(3):63–66.

29.

Trivedi

. The link between depression and physical symptoms. Prim Care Companion J Clin Psychiatry. 2004;6(Suppl 1):12–16. https://www.ncbi.nlm.nih.gov/pubmed/16001092

30.

Oliver

Wittenberg-Lyles

Washington

, et al. Hospice caregivers’ experiences with pain management: “I’m not a doctor, and I don’t know if I helped her go faster or slower”. J Pain Symptom Manage. 2013;46(6):846–858. doi:10.1016/j.jpainsymman.2013.02.011

31.

Meeker

Waldrop

Schneider

Case

. Contending with advanced illness: patient and caregiver perspectives. J Pain Symptom Manage. 2014;47(5):887–895. https://www.clinicalkey.es/playcontent/1-s2.0-S0885392413003941. doi:10.1016/j.jpainsymman.2013.06.009

32.

Teno

Plotzke

Christian

Gozalo

. Examining variation in hospice visits by professional staff in the last 2 days of life. JAMA Intern Med. 2016;176(3):364–370. https://dx-doi-org.web.bisu.edu.cn/10.1001/jamainternmed.2015.7479. doi:10.1001/jamainternmed.2015.7479

33.

Jack

O’Brien

Scrutton

Baldry

Groves

. Supporting family carers providing end-of-life home care: a qualitative study on the impact of a hospice at home service. J Clin Nurs. 2015;24(1-2):131–140. https://onlinelibrary-wiley-com-443.web.bisu.edu.cn/doi/abs/10.1111/jocn.12695. doi:10.1111/jocn.12695

34.

Phongtankuel

Scherban

Reid

, et al. Why do home hospice patients return to the hospital? A study of hospice provider perspectives. J Palliat Med. 2016;19(1):51–56. https://www.liebertpub.com/doi/abs/10.1089/jpm.2015.0178. doi:10.1089/jpm.2015.0178